<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01959529</url>
  </required_header>
  <id_info>
    <org_study_id>EX1250-4080</org_study_id>
    <secondary_id>2013-002371-17</secondary_id>
    <secondary_id>U1111-1141-7614</secondary_id>
    <secondary_id>JapicCTI-142464</secondary_id>
    <nct_id>NCT01959529</nct_id>
  </id_info>
  <brief_title>A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events</brief_title>
  <acronym>DEVOTE</acronym>
  <official_title>A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novo Nordisk A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novo Nordisk A/S</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial is conducted globally. The aim of this trial is to compare cardiovascular safety
      of insulin degludec versus insulin glargine in subjects with type 2 diabetes at high risk of
      cardiovascular events.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 29, 2013</start_date>
  <completion_date type="Actual">October 16, 2016</completion_date>
  <primary_completion_date type="Actual">October 16, 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time From Randomisation to First Occurrence of a Major Adverse Cardiovascular Event (MACE): Cardiovascular Death, Non-fatal Myocardial Infarction, or Non-fatal Stroke</measure>
    <time_frame>From randomisation to individual end of trial date (maximum patient year observation: 2.75 years)</time_frame>
    <description>Time from randomisation to first occurrence of an event adjudication committee (EAC)-confirmed 3-component major adverse cardiovascular event (MACE): cardiovascular death, non-fatal myocardial infarction, or nonfatal stroke. Events with EAC-confirmed onset date between randomisation and individual end of trial were included in the analyses. The number of subjects experiencing first EAC-confirmed MACEs, date between randomisation to the end of trial, both days included were presented. The trial was event driven and planned to last up to a maximum of 60.5 months. The actual trial duration (time from first subject first visit to last subject last visit) was 35.6 months. The maximum trial duration for a single subject was 33.1 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of EAC-confirmed Severe Hypoglycaemic Episodes</measure>
    <time_frame>From randomisation to individual end of trial (maximum patient year observation: 2.75 years)</time_frame>
    <description>Number of severe hypoglycaemic episodes from week 0 to the last assessment (up to 35.6 months). The episode of severe hypoglycaemia is an episode requiring assistance of another person to actively administer carbohydrate, glucagon, or take other corrective actions. The trial was event driven and planned to last up to a maximum of 60.5 months. The actual trial duration (time from first subject first visit to last subject last visit) was 35.6 months. The maximum trial duration for a single subject was 33.1 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of at Least One EAC Confirmed Severe Hypoglycaemic Episode Within a Subject (Yes/no)</measure>
    <time_frame>From randomisation to individual end of trial date (maximum patient year observation: 2.75 years)</time_frame>
    <description>Occurrence of at least one EAC-confirmed severe hypoglycaemic episode within a subject from week 0 to the last assessment (up to 35.6 months). The episode of severe hypoglycaemia is an episode requiring assistance of another person to actively administer carbohydrate, glucagon, or take other corrective actions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Glycosylated Haemoglobin (HbA1c)</measure>
    <time_frame>Randomisation to 24 months</time_frame>
    <description>Mean change in HbA1c from week 0 to month 24.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">7637</enrollment>
  <condition>Diabetes</condition>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Insulin degludec (IDeg)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects will continue their current antidiabetic therapy except for the basal insulin component (if any) that will be replaced by the investigational product.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Insulin glargine (IGlar)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>All subjects will continue their current antidiabetic therapy except for the basal insulin component (if any) that will be replaced by the investigational product.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>insulin degludec</intervention_name>
    <description>Injected once daily subcutaneously (s.c., under the skin)</description>
    <arm_group_label>Insulin degludec (IDeg)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>insulin glargine</intervention_name>
    <description>Injected once daily subcutaneously (s.c., under the skin)</description>
    <arm_group_label>Insulin glargine (IGlar)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes

          -  Age above or equal to 50 years with predefined previous cardiovascular disease(s) or
             renal disease or age above or equal to 60 years with predefined cardiovascular risk
             factors

          -  HbA1c (glycosylated haemoglobin) above or equal to 7.0% or HbA1c below 7.0% and
             current insulin treatment corresponding to above or equal to 20 U of basal insulin per
             day

          -  One or more oral or injectable antidiabetic agent(s)

        Exclusion Criteria:

          -  An acute coronary or cerebrovascular event in the previous 60 days

          -  Planned coronary, carotid or peripheral artery revascularisation

          -  Chronic heart failure NYHA (New York Heart Association) class IV

          -  Current or past (within the last 5 years) malignant neoplasms (except basal cell and
             squamous cell skin carcinoma)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Global Clinical Registry (GCR, 1452)</last_name>
    <role>Study Director</role>
    <affiliation>Novo Nordisk A/S</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Montgomery</city>
        <state>Alabama</state>
        <zip>36106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Montgomery</city>
        <state>Alabama</state>
        <zip>36109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Gilbert</city>
        <state>Arizona</state>
        <zip>85295</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Glendale</city>
        <state>Arizona</state>
        <zip>85308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Litchfield Park</city>
        <state>Arizona</state>
        <zip>85340</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85020</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85714</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85723</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205-5446</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Searcy</city>
        <state>Arkansas</state>
        <zip>72143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chula Vista</city>
        <state>California</state>
        <zip>91910</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Concord</city>
        <state>California</state>
        <zip>94520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Downey</city>
        <state>California</state>
        <zip>90242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Duarte</city>
        <state>California</state>
        <zip>91010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Encino</city>
        <state>California</state>
        <zip>91436</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Greenbrae</city>
        <state>California</state>
        <zip>94904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Huntington Beach</city>
        <state>California</state>
        <zip>92648</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Inglewood</city>
        <state>California</state>
        <zip>90301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>La Mesa</city>
        <state>California</state>
        <zip>91942</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Lancaster</city>
        <state>California</state>
        <zip>93534</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Los Alamitos</city>
        <state>California</state>
        <zip>90720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mission Hills</city>
        <state>California</state>
        <zip>91345</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Montclair</city>
        <state>California</state>
        <zip>91763</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Monterey</city>
        <state>California</state>
        <zip>93940</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>North Hollywood</city>
        <state>California</state>
        <zip>91606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Palm Springs</city>
        <state>California</state>
        <zip>92262</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Poway</city>
        <state>California</state>
        <zip>92064</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>San Ramon</city>
        <state>California</state>
        <zip>94583</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <zip>92704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Sherman Oaks</city>
        <state>California</state>
        <zip>91403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Thousand Oaks</city>
        <state>California</state>
        <zip>91360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tustin</city>
        <state>California</state>
        <zip>92780</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ventura</city>
        <state>California</state>
        <zip>93003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Vista</city>
        <state>California</state>
        <zip>92083</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Westminster</city>
        <state>California</state>
        <zip>92683</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80909</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Golden</city>
        <state>Colorado</state>
        <zip>80401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Danbury</city>
        <state>Connecticut</state>
        <zip>06810</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Norwalk</city>
        <state>Connecticut</state>
        <zip>06851</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Waterbury</city>
        <state>Connecticut</state>
        <zip>06708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33433</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <zip>33472</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bradenton</city>
        <state>Florida</state>
        <zip>34201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Brandon</city>
        <state>Florida</state>
        <zip>33511</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cooper City</city>
        <state>Florida</state>
        <zip>33024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Fleming Island</city>
        <state>Florida</state>
        <zip>32003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33316</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Green Cove Springs</city>
        <state>Florida</state>
        <zip>32043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33155</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33165</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33183</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Naples</city>
        <state>Florida</state>
        <zip>34119</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>New Port Richey</city>
        <state>Florida</state>
        <zip>34652</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Panama City</city>
        <state>Florida</state>
        <zip>32401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ponte Vedra</city>
        <state>Florida</state>
        <zip>32081</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Port Charlotte</city>
        <state>Florida</state>
        <zip>33952</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Port Orange</city>
        <state>Florida</state>
        <zip>32127</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>South Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33619</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33624</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30318</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dunwoody</city>
        <state>Georgia</state>
        <zip>30338</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Lawrenceville</city>
        <state>Georgia</state>
        <zip>30046</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Roswell</city>
        <state>Georgia</state>
        <zip>30076</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31406</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96814</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Idaho Falls</city>
        <state>Idaho</state>
        <zip>83404-7596</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Addison</city>
        <state>Illinois</state>
        <zip>60101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Champaign</city>
        <state>Illinois</state>
        <zip>61821</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60616</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Crystal Lake</city>
        <state>Illinois</state>
        <zip>60012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Gurnee</city>
        <state>Illinois</state>
        <zip>60031</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Hines</city>
        <state>Illinois</state>
        <zip>60141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62711</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Brownsburg</city>
        <state>Indiana</state>
        <zip>46112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Evansville</city>
        <state>Indiana</state>
        <zip>47714</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Franklin</city>
        <state>Indiana</state>
        <zip>46131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Greenfield</city>
        <state>Indiana</state>
        <zip>46140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46254</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Michigan City</city>
        <state>Indiana</state>
        <zip>46360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Muncie</city>
        <state>Indiana</state>
        <zip>47304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Council Bluffs</city>
        <state>Iowa</state>
        <zip>51501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Madisonville</city>
        <state>Kentucky</state>
        <zip>42431</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Monroe</city>
        <state>Louisiana</state>
        <zip>71203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70119</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Slidell</city>
        <state>Louisiana</state>
        <zip>70461-4231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bangor</city>
        <state>Maine</state>
        <zip>04401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Hyattsville</city>
        <state>Maryland</state>
        <zip>20782</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Rockville</city>
        <state>Maryland</state>
        <zip>20852</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Watertown</city>
        <state>Massachusetts</state>
        <zip>02472</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Buckley</city>
        <state>Michigan</state>
        <zip>49620</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49009</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Livonia</city>
        <state>Michigan</state>
        <zip>48152</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48098</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Olive Branch</city>
        <state>Mississippi</state>
        <zip>38654</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Hazelwood</city>
        <state>Missouri</state>
        <zip>63042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Jefferson City</city>
        <state>Missouri</state>
        <zip>65109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <zip>59901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Elkhorn</city>
        <state>Nebraska</state>
        <zip>68022</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Fremont</city>
        <state>Nebraska</state>
        <zip>68025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198-4120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89148</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Nashua</city>
        <state>New Hampshire</state>
        <zip>03063</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>East Brunswick</city>
        <state>New Jersey</state>
        <zip>08816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Hoboken</city>
        <state>New Jersey</state>
        <zip>07030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Lake Success</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>New Windsor</city>
        <state>New York</state>
        <zip>12553</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>North Massapequa</city>
        <state>New York</state>
        <zip>11758-1802</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Northport</city>
        <state>New York</state>
        <zip>11768</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>West Seneca</city>
        <state>New York</state>
        <zip>14224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Westfield</city>
        <state>New York</state>
        <zip>14787</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Burlington</city>
        <state>North Carolina</state>
        <zip>27215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cary</city>
        <state>North Carolina</state>
        <zip>27518</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27517</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Lexington</city>
        <state>North Carolina</state>
        <zip>27292</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Morehead City</city>
        <state>North Carolina</state>
        <zip>28557</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>New Bern</city>
        <state>North Carolina</state>
        <zip>28562</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Statesville</city>
        <state>North Carolina</state>
        <zip>28625</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Whiteville</city>
        <state>North Carolina</state>
        <zip>28472</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <zip>28401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106-1702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Delaware</city>
        <state>Ohio</state>
        <zip>43015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Franklin</city>
        <state>Ohio</state>
        <zip>45005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Maumee</city>
        <state>Ohio</state>
        <zip>43537</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mentor</city>
        <state>Ohio</state>
        <zip>44060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Perrysburg</city>
        <state>Ohio</state>
        <zip>43551</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Norman</city>
        <state>Oklahoma</state>
        <zip>73072</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239-3098</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Altoona</city>
        <state>Pennsylvania</state>
        <zip>16602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Beaver</city>
        <state>Pennsylvania</state>
        <zip>15009</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Hermitage</city>
        <state>Pennsylvania</state>
        <zip>16148</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19152</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15243</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Smithfield</city>
        <state>Pennsylvania</state>
        <zip>15478</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Uniontown</city>
        <state>Pennsylvania</state>
        <zip>15401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Upper Darby</city>
        <state>Pennsylvania</state>
        <zip>19082</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Wilkes-Barre</city>
        <state>Pennsylvania</state>
        <zip>18702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>29621</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <zip>29651</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Moncks Corner</city>
        <state>South Carolina</state>
        <zip>29461</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Murrells Inlet</city>
        <state>South Carolina</state>
        <zip>29576</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Myrtle Beach</city>
        <state>South Carolina</state>
        <zip>29572</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Orangeburg</city>
        <state>South Carolina</state>
        <zip>29118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37404-1192</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37411</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37938</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38119</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38163</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tullahoma</city>
        <state>Tennessee</state>
        <zip>37388</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Arlington</city>
        <state>Texas</state>
        <zip>76012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78731</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78749</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Carrollton</city>
        <state>Texas</state>
        <zip>75007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Carrollton</city>
        <state>Texas</state>
        <zip>75010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Corpus Christi</city>
        <state>Texas</state>
        <zip>78404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390-9302</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77008</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77061</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77070</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77099</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Humble</city>
        <state>Texas</state>
        <zip>77338</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Hurst</city>
        <state>Texas</state>
        <zip>76054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Irving</city>
        <state>Texas</state>
        <zip>75039</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Lewisville</city>
        <state>Texas</state>
        <zip>75067</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Longview</city>
        <state>Texas</state>
        <zip>75605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <zip>79423</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Midland</city>
        <state>Texas</state>
        <zip>79707</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Odessa</city>
        <state>Texas</state>
        <zip>79761</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Pearland</city>
        <state>Texas</state>
        <zip>77584</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Richardson</city>
        <state>Texas</state>
        <zip>75080</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Round Rock</city>
        <state>Texas</state>
        <zip>78681</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78228-6205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78258</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Splendora</city>
        <state>Texas</state>
        <zip>77372</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Sugar Land</city>
        <state>Texas</state>
        <zip>77478</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Sugar Land</city>
        <state>Texas</state>
        <zip>77479</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Waco</city>
        <state>Texas</state>
        <zip>76710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bennington</city>
        <state>Vermont</state>
        <zip>05201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>South Burlington</city>
        <state>Vermont</state>
        <zip>05403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Midlothian</city>
        <state>Virginia</state>
        <zip>23114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Winchester</city>
        <state>Virginia</state>
        <zip>22601-3834</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Richland</city>
        <state>Washington</state>
        <zip>99352</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kenosha</city>
        <state>Wisconsin</state>
        <zip>53144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53295</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Algiers</city>
        <zip>16000</zip>
        <country>Algeria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Constantine</city>
        <zip>25000</zip>
        <country>Algeria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Oran</city>
        <zip>31000</zip>
        <country>Algeria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Sidi Bel Abbes</city>
        <zip>22000</zip>
        <country>Algeria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Caba</city>
        <zip>C1440AAD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cordoba</city>
        <zip>5000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mar del Plata</city>
        <zip>B7600FZN</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Rosario</city>
        <zip>S2000CUD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Zarate</city>
        <zip>B2800DGH</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Fortaleza</city>
        <state>Ceara</state>
        <zip>60115-282</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Brasília</city>
        <state>Distrito Federal</state>
        <zip>71625-009</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Aparecida de Goiania</city>
        <state>Goias</state>
        <zip>74935-530</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Belém</city>
        <state>Para</state>
        <zip>66073-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mogi das Cruzes</city>
        <state>Sao Paulo</state>
        <zip>08780-090</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>São Paulo</city>
        <state>Sao Paulo</state>
        <zip>01223-001</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>São Paulo</city>
        <state>Sao Paulo</state>
        <zip>01228-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>São Paulo</city>
        <state>Sao Paulo</state>
        <zip>01244-030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>São Paulo</city>
        <state>Sao Paulo</state>
        <zip>05403-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Fortaleza</city>
        <zip>60430-350</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Porto Alegre</city>
        <zip>90035-170</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T5J 3N4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3E 3P4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chatham</city>
        <state>Ontario</state>
        <zip>N7L 1C1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1K 4L2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Sarnia</city>
        <state>Ontario</state>
        <zip>N7T 4X3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Laval</city>
        <state>Quebec</state>
        <zip>H7T 2P5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bjelovar</city>
        <zip>43000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Osijek</city>
        <zip>31 000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Slavonski Brod</city>
        <zip>35 000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Zagreb</city>
        <zip>10 000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Athens</city>
        <zip>GR-10552</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Athens</city>
        <zip>GR-115 27</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Athens</city>
        <zip>GR-11527</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Athens</city>
        <zip>GR-17562</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Thessaloniki</city>
        <zip>GR-54642</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Thessaloniki</city>
        <zip>GR-57001</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Hyderabad</city>
        <state>Andhra Pradesh</state>
        <zip>500034</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Hyderbad</city>
        <state>Andhra Pradesh</state>
        <zip>500 012</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <zip>380006</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <zip>380007</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <zip>380016</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <zip>380052</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Gurgaon</city>
        <state>Haryana</state>
        <zip>122001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <zip>560 017</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <zip>560034</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kozhikode</city>
        <state>Kerala</state>
        <zip>673017</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Indore</city>
        <state>Madhya Pradesh</state>
        <zip>452010</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Goa</city>
        <state>Maharashtra</state>
        <zip>403 202</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mumbai</city>
        <state>Maharashtra</state>
        <zip>400007</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mumbai</city>
        <state>Maharashtra</state>
        <zip>400008</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mumbai</city>
        <state>Maharashtra</state>
        <zip>400010</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mumbai</city>
        <state>Maharashtra</state>
        <zip>400012</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mumbai</city>
        <state>Maharashtra</state>
        <zip>400022</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411040</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>New Dehli</city>
        <state>New Delhi</state>
        <zip>110029</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bhubaneswar</city>
        <state>Orissa</state>
        <zip>751005</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Mohali</city>
        <state>Punjab</state>
        <zip>160062</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chennai</city>
        <state>Tamil Nadu</state>
        <zip>600031</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chennai</city>
        <state>Tamil Nadu</state>
        <zip>600086</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Coimbatore</city>
        <state>Tamil Nadu</state>
        <zip>641018</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Lucknow</city>
        <state>Uttar Pradesh</state>
        <zip>226014</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kolkata</city>
        <state>West Bengal</state>
        <zip>700020</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kolkata</city>
        <state>West Bengal</state>
        <zip>700054</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ludhiana</city>
        <zip>141001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>New Delhi</city>
        <zip>110001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bari</city>
        <zip>70124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bergamo</city>
        <zip>24127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Catanzaro</city>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chieti Scalo</city>
        <zip>66100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Milano (MI)</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Milano</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Milano</city>
        <zip>20162</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Olbia</city>
        <zip>07026</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Padova</city>
        <zip>35143</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Palermo</city>
        <zip>90127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ravenna</city>
        <zip>48121</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Roma</city>
        <zip>00133</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Roma</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Sesto San Giovanni (MI)</city>
        <zip>20099</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chuo-ku, Tokyo</city>
        <zip>103 0002</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kumamoto-shi,Kumamoto</city>
        <zip>862 0976</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Matsumoto-shi, Nagano</city>
        <zip>390-8621</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Miyazaki-shi</city>
        <zip>880 0034</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ota-ku, Tokyo</city>
        <zip>1430015</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ota-ku</city>
        <zip>144 0035</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tokyo</city>
        <zip>162-8655</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Yokohama-shi</city>
        <zip>235 0045</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Goyang</city>
        <zip>10380</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>02841</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Suwon-si, Gyeonggi-do</city>
        <zip>16247</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Alor Setar</city>
        <zip>05460</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kota Samarahan</city>
        <zip>94300</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>59100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kuantan</city>
        <zip>25100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Melaka</city>
        <zip>75400</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Serdang</city>
        <zip>43000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Seremban</city>
        <zip>70300</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44130</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44150</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44600</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44650</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44670</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cuernavaca</city>
        <state>Morelos</state>
        <zip>62250</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Distrito Federal</city>
        <state>México, D.F.</state>
        <zip>14000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Aguascalientes</city>
        <zip>20230</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chihuahua</city>
        <zip>31200</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>San Luis Potosi</city>
        <zip>78200</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bytom</city>
        <zip>41-902</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Gdansk</city>
        <zip>80-546</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Krakow</city>
        <zip>31-455</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Oswiecim</city>
        <zip>32-600</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Poznan</city>
        <zip>60-589</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Szczecin</city>
        <zip>70-506</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Warszawa</city>
        <zip>02-507</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Zamosc</city>
        <zip>22-400</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Alba Iulia</city>
        <state>Alba</state>
        <zip>510053</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Baia Mare</city>
        <state>Maramures</state>
        <zip>430222</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Targu Mures</city>
        <state>Mures</state>
        <zip>540142</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ploiesti</city>
        <state>Prahova</state>
        <zip>100163</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ekaterinburg</city>
        <zip>620102</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kemerovo</city>
        <zip>650002</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Kirov</city>
        <zip>610014</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Krasnodar</city>
        <zip>350012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Krasnodar</city>
        <zip>350086</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>111539</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>123423</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Nizhny Novgorod</city>
        <zip>603018</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Rostov-on-Don</city>
        <zip>344068</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>191119</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>194356</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>195213</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Saratov</city>
        <zip>410031</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Saratov</city>
        <zip>410053</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <zip>194354</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <zip>195257</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Syktyvkar</city>
        <zip>167981</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tumen</city>
        <zip>625023</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Tver</city>
        <zip>170036</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Ulianovsk</city>
        <zip>432063</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Volgograd</city>
        <zip>400131</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150010</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Port Elizabeth</city>
        <state>Eastern Cape</state>
        <zip>6014</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Port Elizabeth</city>
        <state>Eastern Cape</state>
        <zip>6045</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Johannesburg</city>
        <state>Gauteng</state>
        <zip>1818</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Johannesburg</city>
        <state>Gauteng</state>
        <zip>2193</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Johannesburg</city>
        <state>Gauteng</state>
        <zip>2198</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Pretoria</city>
        <state>Gauteng</state>
        <zip>0001</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Durban</city>
        <state>KwaZulu-Natal</state>
        <zip>4001</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Durban</city>
        <state>KwaZulu-Natal</state>
        <zip>4092</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Umkomaas</city>
        <state>KwaZulu-Natal</state>
        <zip>4170</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Middleburg</city>
        <state>Mpumalanga</state>
        <zip>1055</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Brits</city>
        <state>North West</state>
        <zip>0250</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cape Town</city>
        <state>Western Cape</state>
        <zip>7130</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cape Town</city>
        <state>Western Cape</state>
        <zip>7460</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cape Town</city>
        <state>Western Cape</state>
        <zip>7500</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Cape Town</city>
        <state>Western Cape</state>
        <zip>7700</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Granada</city>
        <zip>18003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Granada</city>
        <zip>18012</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Málaga</city>
        <zip>29006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Valencia</city>
        <zip>46014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Valencia</city>
        <zip>46015</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bangkoknoi, Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Chiang Mai</city>
        <zip>50200</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Nakhon Ratchasima</city>
        <zip>30000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Bristol</city>
        <zip>BS10 5NB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Dundee</city>
        <zip>DD1 9SY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH4 2XU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Guildford</city>
        <zip>GU2 7XX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Norwich</city>
        <zip>NR4 7TJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Nuneaton</city>
        <zip>CV10 7DJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Stevenage</city>
        <zip>SG1 4AB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Wolverhampton</city>
        <zip>WV10 0QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Algeria</country>
    <country>Argentina</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>Croatia</country>
    <country>Greece</country>
    <country>India</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Malaysia</country>
    <country>Mexico</country>
    <country>Poland</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Thailand</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://novonordisk-trials.com</url>
    <description>Clinical Trials at Novo Nordisk</description>
  </link>
  <results_reference>
    <citation>Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Frandsen KB, Rabøl R, Buse JB. Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) - DEVOTE 1. Am Heart J. 2016 Sep;179:175-83. doi: 10.1016/j.ahj.2016.06.004. Epub 2016 Jun 18.</citation>
    <PMID>27595693</PMID>
  </results_reference>
  <results_reference>
    <citation>Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12.</citation>
    <PMID>28605603</PMID>
  </results_reference>
  <results_reference>
    <citation>Zinman B, Marso SP, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Lange M, Brown-Frandsen K, Moses A, Ocampo Francisco AM, Barner Lekdorf J, Kvist K, Buse JB; DEVOTE Study Group. Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2). Diabetologia. 2018 Jan;61(1):48-57. doi: 10.1007/s00125-017-4423-z. Epub 2017 Sep 15.</citation>
    <PMID>28913575</PMID>
  </results_reference>
  <results_reference>
    <citation>Pieber TR, Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pratley RE, Woo V, Heller S, Lange M, Brown-Frandsen K, Moses A, Barner Lekdorf J, Lehmann L, Kvist K, Buse JB; DEVOTE Study Group. DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality. Diabetologia. 2018 Jan;61(1):58-65. doi: 10.1007/s00125-017-4422-0. Epub 2017 Sep 15.</citation>
    <PMID>28913543</PMID>
  </results_reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 8, 2013</study_first_submitted>
  <study_first_submitted_qc>October 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2013</study_first_posted>
  <results_first_submitted>October 16, 2017</results_first_submitted>
  <results_first_submitted_qc>October 16, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">November 17, 2017</results_first_posted>
  <last_update_submitted>December 20, 2017</last_update_submitted>
  <last_update_submitted_qc>December 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin Glargine</mesh_term>
    <mesh_term>Insulin, Long-Acting</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The trial was conducted at 438 sites in 20 countries as follows: Algeria: 6; Argentina: 4; Brazil: 10; Canada: 6; Croatia: 5; Greece: 6; India: 26; Italy: 10; Japan: 8; Republic of Korea: 4; Malaysia: 8; Mexico: 7; Poland: 8; Romania: 4; Russian Federation: 20; South Africa: 15; Spain: 6; Thailand: 6; United Kingdom: 8; United States: 271.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Insulin Degludec</title>
          <description>Subjects received insulin degludec (IDeg) 100 units/mL once daily (OD) subcutaneously (S.C.; under the skin) in the thigh, upper arm, or the abdominal wall between dinner and bedtime. Subjects continued their pre-trial medication except for the basal insulin, which was replaced by investigational medicinal product (IMP; IDeg). The pre-trial bolus insulin was allowed and could be replaced with insulin aspart (IAsp) at the discretion of the investigator. For subjects previously receiving premixed/biphasic insulin the basal component was calculated and switched to IDeg OD, and the bolus insulin component to bolus insulin. For subjects previously receiving premixed/biphasic insulin twice daily (BID), the total basal component was calculated, reduced by 20- 30% and switched to IDeg OD, and the bolus component was calculated and switched to IAsp. The trial was event driven for with a realised observation period up to 33 months.</description>
        </group>
        <group group_id="P2">
          <title>Insulin Glargine</title>
          <description>Subjects received insulin glargine (IGlar) 100 units/mL OD subcutaneously (S.C.; under the skin) in the thigh, upper arm, or the abdominal wall between dinner and bedtime. Subjects continued their pretrial medication except for the basal insulin, which was replaced by investigational medicinal product (IMP; IGlar). The pre-trial bolus insulin was allowed and could be replaced with IAsp at the discretion of the investigator. For subjects previously receiving premixed/biphasic insulin the basal component was calculated and switched to IGlar OD, and the bolus insulin component to bolus insulin. For subjects previously receiving premixed/biphasic insulin BID, the total basal component was calculated, reduced by 20- 30% and switched to IGlar OD, and the bolus component was calculated and switched to IAsp. The trial was event driven with a realised observation period up to 33 months.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3818"/>
                <participants group_id="P2" count="3819"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Exposed</title>
              <participants_list>
                <participants group_id="P1" count="3809"/>
                <participants group_id="P2" count="3806"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3742"/>
                <participants group_id="P2" count="3747"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="76"/>
                <participants group_id="P2" count="72"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse event (not hypoglycaemia)</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="70"/>
                <participants group_id="P2" count="68"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Hypoglycaemia</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of glycaemic control</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Baseline analysis was based on the full analysis set (FAS), which included all randomised subjects.</population>
      <group_list>
        <group group_id="B1">
          <title>Insulin Degludec</title>
          <description>Subjects received IDeg 100 units/mL OD S.C. (under the skin) in the thigh, upper arm, or the abdominal wall between dinner and bedtime. Subjects continued their pre-trial medication except for the basal insulin, which was replaced by investigational medicinal product (IMP; IDeg). The pre-trial bolus insulin was allowed and could be replaced with IAsp at the discretion of the investigator. For subjects previously receiving premixed/biphasic insulin the basal component was calculated and switched to IDeg OD, and the bolus insulin component to bolus insulin. For subjects previously receiving premixed/biphasic insulin BID, the total basal component was calculated, reduced by 20- 30% and switched to IDeg OD, and the bolus component was calculated and switched to IAsp. The trial was event driven for with a realised observation period up to 33 months.</description>
        </group>
        <group group_id="B2">
          <title>Insulin Glargine</title>
          <description>Subjects received IGlar 100 units/mL OD subcutaneously (S.C.; under the skin) in the thigh, upper arm, or the abdominal wall between dinner and bedtime. Subjects continued their pretrial medication except for the basal insulin, which was replaced by investigational medicinal product (IMP; IGlar). The pre-trial bolus insulin was allowed and could be replaced with IAsp at the discretion of the investigator. For subjects previously receiving premixed/biphasic insulin the basal component was calculated and switched to IGlar OD, and the bolus insulin component to bolus insulin. For subjects previously receiving premixed/biphasic insulin BID, the total basal component was calculated, reduced by 20- 30% and switched to IGlar OD, and the bolus component was calculated and switched to IAsp. The trial was event driven with a realised observation period up to 33 months.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3818"/>
            <count group_id="B2" value="3819"/>
            <count group_id="B3" value="7637"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.9" spread="7.3"/>
                    <measurement group_id="B2" value="65.0" spread="7.5"/>
                    <measurement group_id="B3" value="65.0" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1422"/>
                    <measurement group_id="B2" value="1437"/>
                    <measurement group_id="B3" value="2859"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2396"/>
                    <measurement group_id="B2" value="2382"/>
                    <measurement group_id="B3" value="4778"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>HbA1c</title>
          <units>percentage of HbA1c</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.44" spread="1.63"/>
                    <measurement group_id="B2" value="8.41" spread="1.67"/>
                    <measurement group_id="B3" value="8.43" spread="1.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time From Randomisation to First Occurrence of a Major Adverse Cardiovascular Event (MACE): Cardiovascular Death, Non-fatal Myocardial Infarction, or Non-fatal Stroke</title>
        <description>Time from randomisation to first occurrence of an event adjudication committee (EAC)-confirmed 3-component major adverse cardiovascular event (MACE): cardiovascular death, non-fatal myocardial infarction, or nonfatal stroke. Events with EAC-confirmed onset date between randomisation and individual end of trial were included in the analyses. The number of subjects experiencing first EAC-confirmed MACEs, date between randomisation to the end of trial, both days included were presented. The trial was event driven and planned to last up to a maximum of 60.5 months. The actual trial duration (time from first subject first visit to last subject last visit) was 35.6 months. The maximum trial duration for a single subject was 33.1 months.</description>
        <time_frame>From randomisation to individual end of trial date (maximum patient year observation: 2.75 years)</time_frame>
        <population>The analysis was based on the FAS, which included all randomised subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>Insulin Degludec</title>
            <description>Subjects received IDeg 100 units/mL OD S.C. (under the skin) in the thigh, upper arm, or the abdominal wall between dinner and bedtime. Subjects continued their pre-trial medication except for the basal insulin, which was replaced by investigational medicinal product (IMP; IDeg). The pre-trial bolus insulin was allowed and could be replaced with IAsp at the discretion of the investigator. For subjects previously receiving premixed/biphasic insulin the basal component was calculated and switched to IDeg OD, and the bolus insulin component to bolus insulin. For subjects previously receiving premixed/biphasic insulin BID, the total basal component was calculated, reduced by 20- 30% and switched to IDeg OD, and the bolus component was calculated and switched to IAsp. The trial was event driven for with a realised observation period up to 33 months.</description>
          </group>
          <group group_id="O2">
            <title>Insulin Glargine</title>
            <description>Subjects received IGlar 100 units/mL OD subcutaneously (S.C.; under the skin) in the thigh, upper arm, or the abdominal wall between dinner and bedtime. Subjects continued their pretrial medication except for the basal insulin, which was replaced by investigational medicinal product (IMP; IGlar). The pre-trial bolus insulin was allowed and could be replaced with IAsp at the discretion of the investigator. For subjects previously receiving premixed/biphasic insulin the basal component was calculated and switched to IGlar OD, and the bolus insulin component to bolus insulin. For subjects previously receiving premixed/biphasic insulin BID, the total basal component was calculated, reduced by 20- 30% and switched to IGlar OD, and the bolus component was calculated and switched to IAsp. The trial was event driven with a realised observation period up to 33 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Randomisation to First Occurrence of a Major Adverse Cardiovascular Event (MACE): Cardiovascular Death, Non-fatal Myocardial Infarction, or Non-fatal Stroke</title>
          <description>Time from randomisation to first occurrence of an event adjudication committee (EAC)-confirmed 3-component major adverse cardiovascular event (MACE): cardiovascular death, non-fatal myocardial infarction, or nonfatal stroke. Events with EAC-confirmed onset date between randomisation and individual end of trial were included in the analyses. The number of subjects experiencing first EAC-confirmed MACEs, date between randomisation to the end of trial, both days included were presented. The trial was event driven and planned to last up to a maximum of 60.5 months. The actual trial duration (time from first subject first visit to last subject last visit) was 35.6 months. The maximum trial duration for a single subject was 33.1 months.</description>
          <population>The analysis was based on the FAS, which included all randomised subjects.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3818"/>
                <count group_id="O2" value="3819"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>First EAC-confirmed MACE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="325"/>
                    <measurement group_id="O2" value="356"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myocardial infarction (non-fatal)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="143"/>
                    <measurement group_id="O2" value="163"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stroke (non-fatal)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68"/>
                    <measurement group_id="O2" value="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cardiovascular death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="114"/>
                    <measurement group_id="O2" value="119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The hazard ratio (HR) (IDeg vs IGlar) was based on Cox regression with investigational medicinal product as only factor for primary analysis.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority of IDeg to IGlar was considered confirmed if the upper limit of the two-sided 95% confidence interval for the HR was below 1.3 or equivalent if the p-value for the one-sided test of null hypothesis (H0): HR≥1.3 against the alternative hypothesis (Ha): HR&lt;1.3 was less than 2.5%.</non_inferiority_desc>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>p value : Refers to one-sided test of HR &gt;= 1.3 (against Ha: HR&lt;1.3).</p_value_desc>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.908</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.781</ci_lower_limit>
            <ci_upper_limit>1.055</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of EAC-confirmed Severe Hypoglycaemic Episodes</title>
        <description>Number of severe hypoglycaemic episodes from week 0 to the last assessment (up to 35.6 months). The episode of severe hypoglycaemia is an episode requiring assistance of another person to actively administer carbohydrate, glucagon, or take other corrective actions. The trial was event driven and planned to last up to a maximum of 60.5 months. The actual trial duration (time from first subject first visit to last subject last visit) was 35.6 months. The maximum trial duration for a single subject was 33.1 months.</description>
        <time_frame>From randomisation to individual end of trial (maximum patient year observation: 2.75 years)</time_frame>
        <population>The analysis was based on the FAS, which included all randomised subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>Insulin Degludec</title>
            <description>Subjects received IDeg 100 units/mL OD S.C. (under the skin) in the thigh, upper arm, or the abdominal wall between dinner and bedtime. Subjects continued their pre-trial medication except for the basal insulin, which was replaced by investigational medicinal product (IMP; IDeg). The pre-trial bolus insulin was allowed and could be replaced with IAsp at the discretion of the investigator. For subjects previously receiving premixed/biphasic insulin the basal component was calculated and switched to IDeg OD, and the bolus insulin component to bolus insulin. For subjects previously receiving premixed/biphasic insulin BID, the total basal component was calculated, reduced by 20- 30% and switched to IDeg OD, and the bolus component was calculated and switched to IAsp. The trial was event driven for with a realised observation period up to 33 months.</description>
          </group>
          <group group_id="O2">
            <title>Insulin Glargine</title>
            <description>Subjects received IGlar 100 units/mL OD subcutaneously (S.C.; under the skin) in the thigh, upper arm, or the abdominal wall between dinner and bedtime. Subjects continued their pretrial medication except for the basal insulin, which was replaced by investigational medicinal product (IMP; IGlar). The pre-trial bolus insulin was allowed and could be replaced with IAsp at the discretion of the investigator. For subjects previously receiving premixed/biphasic insulin the basal component was calculated and switched to IGlar OD, and the bolus insulin component to bolus insulin. For subjects previously receiving premixed/biphasic insulin BID, the total basal component was calculated, reduced by 20- 30% and switched to IGlar OD, and the bolus component was calculated and switched to IAsp. The trial was event driven with a realised observation period up to 33 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of EAC-confirmed Severe Hypoglycaemic Episodes</title>
          <description>Number of severe hypoglycaemic episodes from week 0 to the last assessment (up to 35.6 months). The episode of severe hypoglycaemia is an episode requiring assistance of another person to actively administer carbohydrate, glucagon, or take other corrective actions. The trial was event driven and planned to last up to a maximum of 60.5 months. The actual trial duration (time from first subject first visit to last subject last visit) was 35.6 months. The maximum trial duration for a single subject was 33.1 months.</description>
          <population>The analysis was based on the FAS, which included all randomised subjects.</population>
          <units>Number of severe episodes</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3818"/>
                <count group_id="O2" value="3819"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="280"/>
                    <measurement group_id="O2" value="472"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Superiority was considered confirmed if the upper limit of the two-sided 95% confidence interval for the rate ratio (RR) was below 1.0 or equivalent if the p-value for the one-sided test of H0: RR ≥1.0 against Ha: RR &lt;1.0, was less than 2.5%</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>p-value : Refers to one-sided test of RR &gt;= 1.0 (against Ha: RR&lt;1.0)</p_value_desc>
            <method>Negative binomial regression</method>
            <method_desc>The model included treatment (IDeg vs IGlar) as a fixed factor and was fitted using the FAS.</method_desc>
            <param_type>Rate ratio</param_type>
            <param_value>0.601</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.476</ci_lower_limit>
            <ci_upper_limit>0.759</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Occurrence of at Least One EAC Confirmed Severe Hypoglycaemic Episode Within a Subject (Yes/no)</title>
        <description>Occurrence of at least one EAC-confirmed severe hypoglycaemic episode within a subject from week 0 to the last assessment (up to 35.6 months). The episode of severe hypoglycaemia is an episode requiring assistance of another person to actively administer carbohydrate, glucagon, or take other corrective actions.</description>
        <time_frame>From randomisation to individual end of trial date (maximum patient year observation: 2.75 years)</time_frame>
        <population>The analysis was based on the FAS, which included all randomised subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>Insulin Degludec</title>
            <description>Subjects received IDeg 100 units/mL OD S.C. (under the skin) in the thigh, upper arm, or the abdominal wall between dinner and bedtime. Subjects continued their pre-trial medication except for the basal insulin, which was replaced by investigational medicinal product (IMP; IDeg). The pre-trial bolus insulin was allowed and could be replaced with IAsp at the discretion of the investigator. For subjects previously receiving premixed/biphasic insulin the basal component was calculated and switched to IDeg OD, and the bolus insulin component to bolus insulin. For subjects previously receiving premixed/biphasic insulin BID, the total basal component was calculated, reduced by 20- 30% and switched to IDeg OD, and the bolus component was calculated and switched to IAsp. The trial was event driven for with a realised observation period up to 33 months.</description>
          </group>
          <group group_id="O2">
            <title>Insulin Glargine</title>
            <description>Subjects received IGlar 100 units/mL OD subcutaneously (S.C.; under the skin) in the thigh, upper arm, or the abdominal wall between dinner and bedtime. Subjects continued their pretrial medication except for the basal insulin, which was replaced by investigational medicinal product (IMP; IGlar). The pre-trial bolus insulin was allowed and could be replaced with IAsp at the discretion of the investigator. For subjects previously receiving premixed/biphasic insulin the basal component was calculated and switched to IGlar OD, and the bolus insulin component to bolus insulin. For subjects previously receiving premixed/biphasic insulin BID, the total basal component was calculated, reduced by 20- 30% and switched to IGlar OD, and the bolus component was calculated and switched to IAsp. The trial was event driven with a realised observation period up to 33 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Occurrence of at Least One EAC Confirmed Severe Hypoglycaemic Episode Within a Subject (Yes/no)</title>
          <description>Occurrence of at least one EAC-confirmed severe hypoglycaemic episode within a subject from week 0 to the last assessment (up to 35.6 months). The episode of severe hypoglycaemia is an episode requiring assistance of another person to actively administer carbohydrate, glucagon, or take other corrective actions.</description>
          <population>The analysis was based on the FAS, which included all randomised subjects.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3818"/>
                <count group_id="O2" value="3819"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="187"/>
                    <measurement group_id="O2" value="252"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Superiority of IDeg to IGlar was considered confirmed if the upper limit of the two-sided 95% confidence interval for the odds ratio (OR) was below 1.0 or equivalent if the p-value for the one-sided test of H0: OR ≥1.0 against Ha: OR&lt;1.0, was less than 2.5%.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>p-value: Refers to one-sided test of OR &gt;= 1.0 (against Ha: OR&lt;1.0)</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>The model was logistic regression with log-link function.The model included treatment (IDeg vs IGlar) as a fixed factor and was fitted using the FAS</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.729</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.600</ci_lower_limit>
            <ci_upper_limit>0.866</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Glycosylated Haemoglobin (HbA1c)</title>
        <description>Mean change in HbA1c from week 0 to month 24.</description>
        <time_frame>Randomisation to 24 months</time_frame>
        <population>The analysis was based on the FAS. The number of subjects analysed are the number of subjects with the available data after 24 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Insulin Degludec</title>
            <description>Subjects received IDeg 100 units/mL OD S.C. (under the skin) in the thigh, upper arm, or the abdominal wall between dinner and bedtime. Subjects continued their pre-trial medication except for the basal insulin, which was replaced by investigational medicinal product (IMP; IDeg). The pre-trial bolus insulin was allowed and could be replaced with IAsp at the discretion of the investigator. For subjects previously receiving premixed/biphasic insulin the basal component was calculated and switched to IDeg OD, and the bolus insulin component to bolus insulin. For subjects previously receiving premixed/biphasic insulin BID, the total basal component was calculated, reduced by 20- 30% and switched to IDeg OD, and the bolus component was calculated and switched to IAsp. The trial was event driven for with a realised observation period up to 33 months.</description>
          </group>
          <group group_id="O2">
            <title>Insulin Glargine</title>
            <description>Subjects received IGlar 100 units/mL OD subcutaneously (S.C.; under the skin) in the thigh, upper arm, or the abdominal wall between dinner and bedtime. Subjects continued their pretrial medication except for the basal insulin, which was replaced by investigational medicinal product (IMP; IGlar). The pre-trial bolus insulin was allowed and could be replaced with IAsp at the discretion of the investigator. For subjects previously receiving premixed/biphasic insulin the basal component was calculated and switched to IGlar OD, and the bolus insulin component to bolus insulin. For subjects previously receiving premixed/biphasic insulin BID, the total basal component was calculated, reduced by 20- 30% and switched to IGlar OD, and the bolus component was calculated and switched to IAsp. The trial was event driven with a realised observation period up to 33 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Glycosylated Haemoglobin (HbA1c)</title>
          <description>Mean change in HbA1c from week 0 to month 24.</description>
          <population>The analysis was based on the FAS. The number of subjects analysed are the number of subjects with the available data after 24 months.</population>
          <units>percentage of HbA1c</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2431"/>
                <count group_id="O2" value="2404"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.86" spread="1.51"/>
                    <measurement group_id="O2" value="-0.84" spread="1.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The adverse events were considered from the randomisation visit (week 0) to the follow up visit (end of treatment plus at least 30 days). The trial was event driven and planned to last up to a maximum of 60.5 months. The maximum trial duration for a single subject was 33.1 months.</time_frame>
      <desc>Safety was summarised using the FAS, which included all randomised subjects.</desc>
      <group_list>
        <group group_id="E1">
          <title>Insulin Degludec</title>
          <description>Subjects received IDeg 100 units/mL OD S.C. (under the skin) in the thigh, upper arm, or the abdominal wall between dinner and bedtime. Subjects continued their pre-trial medication except for the basal insulin, which was replaced by investigational medicinal product (IMP; IDeg). The pre-trial bolus insulin was allowed and could be replaced with IAsp at the discretion of the investigator. For subjects previously receiving premixed/biphasic insulin the basal component was calculated and switched to IDeg OD, and the bolus insulin component to bolus insulin. For subjects previously receiving premixed/biphasic insulin BID, the total basal component was calculated, reduced by 20- 30% and switched to IDeg OD, and the bolus component was calculated and switched to IAsp. The trial was event driven for with a realised observation period up to 33 months.</description>
        </group>
        <group group_id="E2">
          <title>Insulin Glargine</title>
          <description>Subjects received IGlar 100 units/mL OD subcutaneously (S.C.; under the skin) in the thigh, upper arm, or the abdominal wall between dinner and bedtime. Subjects continued their pretrial medication except for the basal insulin, which was replaced by investigational medicinal product (IMP; IGlar). The pre-trial bolus insulin was allowed and could be replaced with IAsp at the discretion of the investigator. For subjects previously receiving premixed/biphasic insulin the basal component was calculated and switched to IGlar OD, and the bolus insulin component to bolus insulin. For subjects previously receiving premixed/biphasic insulin BID, the total basal component was calculated, reduced by 20- 30% and switched to IGlar OD, and the bolus component was calculated and switched to IAsp. The trial was event driven with a realised observation period up to 33 months.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1473" subjects_at_risk="3818"/>
                <counts group_id="E2" subjects_affected="1517" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="3818"/>
                <counts group_id="E2" events="40" subjects_affected="34" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Autoimmune haemolytic anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Coombs negative haemolytic anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Evans syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Haemolytic anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Haemorrhagic anaemia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3818"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypochromic anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Nephrogenic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Normochromic normocytic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="3818"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Acute left ventricular failure</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3818"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="111" subjects_affected="98" subjects_at_risk="3818"/>
                <counts group_id="E2" events="123" subjects_affected="115" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="37" subjects_affected="36" subjects_at_risk="3818"/>
                <counts group_id="E2" events="53" subjects_affected="48" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" events="94" subjects_affected="87" subjects_at_risk="3818"/>
                <counts group_id="E2" events="93" subjects_affected="79" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Aortic valve disease</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Arteriospasm coronary</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="55" subjects_affected="47" subjects_at_risk="3818"/>
                <counts group_id="E2" events="75" subjects_affected="56" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="3818"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Atrioventricular block first degree</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Atrioventricular dissociation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="3818"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bundle branch block left</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bundle branch block right</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="26" subjects_affected="26" subjects_at_risk="3818"/>
                <counts group_id="E2" events="21" subjects_affected="20" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="26" subjects_affected="24" subjects_at_risk="3818"/>
                <counts group_id="E2" events="33" subjects_affected="30" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3818"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" events="12" subjects_affected="8" subjects_at_risk="3818"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="177" subjects_affected="134" subjects_at_risk="3818"/>
                <counts group_id="E2" events="206" subjects_affected="143" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac hypertrophy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac ventricular thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="3818"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiomegaly</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiorenal syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiovascular disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Chordae tendinae rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Chronic left ventricular failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cor pulmonale</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cor pulmonale acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="85" subjects_affected="80" subjects_at_risk="3818"/>
                <counts group_id="E2" events="91" subjects_affected="89" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Coronary artery dissection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Coronary artery embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Coronary artery insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="3818"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Coronary ostial stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diastolic dysfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Heart valve incompetence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypertensive cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypertensive heart disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intracardiac thrombus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Left ventricular dysfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Left ventricular hypertrophy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Long QT syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="51" subjects_affected="48" subjects_at_risk="3818"/>
                <counts group_id="E2" events="68" subjects_affected="66" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3818"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Nodal arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Prinzmetal angina</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pulseless electrical activity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Restrictive cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Right ventricular failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Silent myocardial infarction</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Sinus arrest</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Sinus node dysfunction</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Stress cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Systolic dysfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Tachyarrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Tricuspid valve incompetence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Trifascicular block</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ventricular hypokinesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="3818"/>
                <counts group_id="E2" events="16" subjects_affected="12" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Congenital ureterocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Factor V deficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastrointestinal arteriovenous malformation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Haemorrhagic arteriovenous malformation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypertrophic cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Osteogenesis imperfecta</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Phimosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness neurosensory</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Inner ear disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Meniere's disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Sudden hearing loss</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Vestibular disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Thyroid mass</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Toxic goitre</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Toxic nodular goitre</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blindness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="13" subjects_affected="9" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cataract diabetic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diabetic retinopathy</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Macular fibrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Neurotrophic keratopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Optic ischaemic neuropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pterygium</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Retinal vein occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Retinopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Retinopathy proliferative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Visual impairment</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Abdominal hernia obstructive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Abdominal mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="3818"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Abdominal wall haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Acid peptic disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Acute abdomen</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Alcoholic pancreatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Appendix disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Barrett's oesophagus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Chronic gastritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3818"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" events="6" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diabetic gastroparesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="14" subjects_affected="11" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diverticular perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Duodenal stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Duodenal vascular ectasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Enterocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Epigastric discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Erosive duodenitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastric antral vascular ectasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastric perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastric ulcer perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3818"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastroduodenitis haemorrhagic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastrointestinal angiodysplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="3818"/>
                <counts group_id="E2" events="16" subjects_affected="15" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastrointestinal polyp haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastrointestinal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="3818"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ileus paralytic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Impaired gastric emptying</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intra-abdominal haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Large intestinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Large intestinal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Mallory-Weiss syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Mesenteric haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Neutropenic colitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Oesophageal rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Oesophageal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Oesophageal varices haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pancreatic mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="3818"/>
                <counts group_id="E2" events="16" subjects_affected="11" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pancreatitis chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Peptic ulcer perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Periodontal disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pneumatosis intestinalis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Rectal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Salivary gland calculus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Salivary gland mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="3818"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Spigelian hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Varices oesophageal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3818"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac complication associated with device</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Catheter site haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="3818"/>
                <counts group_id="E2" events="22" subjects_affected="21" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Complication associated with device</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="27" subjects_affected="27" subjects_at_risk="3818"/>
                <counts group_id="E2" events="21" subjects_affected="21" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Foreign body reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Local swelling</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Medical device site haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Multiple organ dysfunction syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="48" subjects_affected="47" subjects_at_risk="3818"/>
                <counts group_id="E2" events="63" subjects_affected="54" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Oedema due to cardiac disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Surgical failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Systemic inflammatory response syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Vascular stent restenosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Vascular stent stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Vascular stent thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute hepatic failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Alcoholic liver disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bile duct obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Biliary dyskinesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3818"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Chronic hepatic failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Dilatation intrahepatic duct acquired</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hepatic lesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hepatitis chronic active</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hepatorenal failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hepatorenal syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ischaemic hepatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Jaundice cholestatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Liver disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Non-alcoholic steatohepatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Portal vein thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Sphincter of Oddi dysfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Steatohepatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Anaphylactic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Renal transplant failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Abdominal sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Abdominal wall abscess</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Abdominal wall infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Abscess rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Abscess soft tissue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Acute endocarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Arteriosclerotic gangrene</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bacterial pyelonephritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Beta haemolytic streptococcal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="3818"/>
                <counts group_id="E2" events="21" subjects_affected="21" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bronchitis bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bronchitis viral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Catheter site infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="64" subjects_affected="52" subjects_at_risk="3818"/>
                <counts group_id="E2" events="72" subjects_affected="61" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cellulitis orbital</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cellulitis staphylococcal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cellulitis streptococcal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Chest wall abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cholecystitis infective</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Clostridium difficile infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Colonic abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Dengue fever</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Dermatitis infected</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diabetic foot infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diabetic gangrene</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Disseminated cryptococcosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="13" subjects_affected="11" subjects_at_risk="3818"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Dysentery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Eczema infected</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Empyema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Epiglottitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Escherichia sepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>External ear cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Extradural abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3818"/>
                <counts group_id="E2" events="16" subjects_affected="13" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gas gangrene</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="3818"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastroenteritis Escherichia coli</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Graft infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Groin abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>H1N1 influenza</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Helicobacter gastritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Incision site infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Infected bite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Infected dermal cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Infected seroma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Infected skin ulcer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Infectious colitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Infusion site infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intervertebral discitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Joint abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Klebsiella sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Labyrinthitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Liver abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lyme disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Meningitis aseptic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Meningitis viral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Mucormycosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Necrotising fasciitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Oesophageal candidiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Oral candidiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="26" subjects_affected="20" subjects_at_risk="3818"/>
                <counts group_id="E2" events="23" subjects_affected="22" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Osteomyelitis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Osteomyelitis chronic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Otitis media chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Paraspinal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Paronychia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Perineal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Perirectal abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Peritoneal abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Peritonitis bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pilonidal cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="99" subjects_affected="90" subjects_at_risk="3818"/>
                <counts group_id="E2" events="102" subjects_affected="90" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pneumonia influenzal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pneumonia klebsiella</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pneumonia mycoplasmal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pneumonia pneumococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pneumonia pseudomonal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pneumonia streptococcal</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pneumonia viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Post procedural cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Post procedural sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Postoperative abscess</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Prostate infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Prostatitis Escherichia coli</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pseudomonal bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pulmonary sepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pyuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Rectal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Renal abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Respiratory syncytial virus bronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Salpingitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="37" subjects_affected="36" subjects_at_risk="3818"/>
                <counts group_id="E2" events="31" subjects_affected="31" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Sepsis pasteurella</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Sepsis syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Septic arthritis staphylococcal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Septic embolus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="3818"/>
                <counts group_id="E2" events="13" subjects_affected="12" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Sialoadenitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Soft tissue infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Staphylococcal abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Staphylococcal bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Streptococcal bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Streptococcal sepsis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Subdiaphragmatic abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="37" subjects_affected="34" subjects_at_risk="3818"/>
                <counts group_id="E2" events="37" subjects_affected="30" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Urinary tract infection bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="3818"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Viraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Viral pericarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Vulval abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accident at work</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Anaemia postoperative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Anaesthetic complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Anaesthetic complication pulmonary</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Anastomotic ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Animal bite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Brachial plexus injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Burns third degree</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac valve replacement complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Coronary artery restenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Coronary vascular graft occlusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Craniocerebral injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Drug administration error</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Extra dose administered</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Eye injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="57" subjects_affected="54" subjects_at_risk="3818"/>
                <counts group_id="E2" events="59" subjects_affected="55" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Fibula fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastrointestinal anastomotic leak</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastrointestinal injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastrointestinal stoma complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastrostomy tube site complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ilium fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Incarcerated incisional hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Incision site haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intentional overdose</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Multiple injuries</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pneumothorax traumatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Post concussion syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Post procedural myocardial infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Postoperative fever</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Postoperative ileus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Postoperative respiratory failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Postoperative thoracic procedure complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Postoperative wound complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Procedural complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Procedural haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Procedural hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Procedural intestinal perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pulmonary contusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" events="21" subjects_affected="20" subjects_at_risk="3818"/>
                <counts group_id="E2" events="18" subjects_affected="18" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Stab wound</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Stoma site reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Stress fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Subdural haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Toxicity to various agents</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Transfusion-related acute lung injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Traumatic haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ureteric injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Vascular procedure complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Wrong drug administered</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Arteriogram coronary</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Biopsy lung</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Blood glucose decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Blood magnesium decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Blood potassium decreased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Blood potassium increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac monitoring</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Catheterisation cardiac</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Coagulation time prolonged</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ejection fraction decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Electrocardiogram ST segment abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Electrocardiogram ST segment elevation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Electrocardiogram ST-T change</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Medical observation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Troponin increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="23" subjects_affected="23" subjects_at_risk="3818"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diabetic complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3818"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diabetic metabolic decompensation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hyperammonaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="3818"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="21" subjects_affected="18" subjects_at_risk="3818"/>
                <counts group_id="E2" events="24" subjects_affected="22" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypernatraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="77" subjects_affected="64" subjects_at_risk="3818"/>
                <counts group_id="E2" events="66" subjects_affected="49" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3818"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lactic acidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pseudohyponatraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Ankle deformity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="3818"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Back disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3818"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Chondrocalcinosis pyrophosphate</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Dactylitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Enthesopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Exostosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gouty arthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Haemarthrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Joint effusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" events="13" subjects_affected="12" subjects_at_risk="3818"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Myopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Osteitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="35" subjects_affected="32" subjects_at_risk="3818"/>
                <counts group_id="E2" events="31" subjects_affected="30" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Osteopenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Polymyalgia rheumatica</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pseudarthrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Soft tissue necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Spondylitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Tendon disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Vertebral foraminal stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acute leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Acute lymphocytic leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma gastric</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma of colon</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Adrenal adenoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Adrenal neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Adult T-cell lymphoma/leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma stage III</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of bladder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of thyroid gland</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Benign ovarian tumour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bile duct adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bladder cancer recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bladder cancer stage 0, with cancer in situ</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma recurrent</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma stage I</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bone cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bowen's disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Brain neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Breast cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Breast cancer stage I</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Breast cancer stage II</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Breast cancer stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac valve fibroelastoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cholangiocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Choroid melanoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Chronic myeloid leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Colon cancer metastatic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Colon cancer stage III</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Colorectal cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diffuse large B-cell lymphoma recurrent</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Endometrial adenocarcinoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Fibroma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gallbladder adenocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gallbladder cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastrointestinal cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastrointestinal tract adenoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hepatic cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hepatic cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hepatocellular carcinoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intraductal proliferative breast lesion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Invasive ductal breast carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Leiomyoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma stage II</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma stage IV</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Malignant melanoma in situ</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Malignant peritoneal neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Meningioma benign</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Mesothelioma malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Metastases to lymph nodes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Metastatic renal cell carcinoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Metastatic squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Mucinous endometrial carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Neuroendocrine carcinoma metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer stage I</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Oesophageal adenocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ovarian cancer recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ovarian cancer stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Papillary cystadenoma lymphomatosum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Papillary thyroid cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Parathyroid tumour benign</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Penile squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Phaeochromocytoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pituitary tumour benign</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Plasma cell myeloma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Prostate cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Prostate cancer stage I</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Prostate cancer stage II</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Rectal adenocarcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Rectal adenoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Rectal cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Renal cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Salivary gland cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer extensive stage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Soft tissue sarcoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of lung</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the tongue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Testicular seminoma (pure) stage I</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Testis cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Thyroid cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Tonsil cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Tumour of ampulla of Vater</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ureteric cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Altered state of consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Brain injury</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Brain stem haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Brain stem infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Brain stem stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Carotid artery disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Carotid artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="3818"/>
                <counts group_id="E2" events="15" subjects_affected="14" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cerebellar infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cerebral arteriosclerosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cerebral small vessel ischaemic disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="3818"/>
                <counts group_id="E2" events="23" subjects_affected="22" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cervical myelopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cranial nerve paralysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Dementia Alzheimer's type</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diabetic mononeuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diabetic neuropathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Embolic cerebral infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Epidural lipomatosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Essential tremor</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Facial paralysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Generalised tonic-clonic seizure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Guillain-Barre syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Haemorrhagic cerebral infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Haemorrhagic transformation stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hemiplegic migraine</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hyperglycaemic seizure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypertensive encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic coma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic seizure</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic unconsciousness</sub_title>
                <counts group_id="E1" events="29" subjects_affected="27" subjects_at_risk="3818"/>
                <counts group_id="E2" events="33" subjects_affected="29" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypoxic-ischaemic encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>IIIrd nerve paralysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intensive care unit acquired weakness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intracranial pressure increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ischaemic cerebral infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" events="44" subjects_affected="43" subjects_at_risk="3818"/>
                <counts group_id="E2" events="50" subjects_affected="45" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lacunar stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Memory impairment</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3818"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Migraine-triggered seizure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Mononeuropathy multiplex</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Motor neurone disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Multiple sclerosis relapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Myasthenia gravis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Nerve root compression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Normal pressure hydrocephalus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Peripheral sensory neuropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Post-injection delirium sedation syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Radicular pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Radiculopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Reversible ischaemic neurological deficit</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="3818"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Senile dementia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Spinal cord compression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Spondylitic myelopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Status epilepticus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="27" subjects_affected="25" subjects_at_risk="3818"/>
                <counts group_id="E2" events="29" subjects_affected="24" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Thalamic infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Thalamus haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Thrombotic stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Toxic encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Transient global amnesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="29" subjects_affected="28" subjects_at_risk="3818"/>
                <counts group_id="E2" events="44" subjects_affected="42" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ulnar nerve palsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>VIth nerve paralysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Vascular dementia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Vascular headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Vertebrobasilar insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Visual field defect</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Device failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Device fastener issue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Device inappropriate shock delivery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Device lead damage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Device loosening</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lead dislodgement</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Acute stress disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Affective disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Aggression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bipolar disorder</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Depression suicidal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hallucination, visual</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intentional self-injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3818"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Paranoia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Personality change due to a general medical condition</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Post stroke depression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Post-traumatic stress disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Schizoaffective disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Schizoaffective disorder bipolar type</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Schizophrenia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" events="79" subjects_affected="70" subjects_at_risk="3818"/>
                <counts group_id="E2" events="110" subjects_affected="95" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Acute prerenal failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Anuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Azotaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bladder neck obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bladder outlet obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Chronic kidney disease</sub_title>
                <counts group_id="E1" events="18" subjects_affected="16" subjects_at_risk="3818"/>
                <counts group_id="E2" events="30" subjects_affected="26" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cystitis noninfective</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diabetic nephropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>End stage renal disease</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="3818"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Glomerulonephritis rapidly progressive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="3818"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Nephropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Nephropathy toxic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Nephrosclerosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Nephrotic syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="3818"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Renal mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Renal tubular necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Stag horn calculus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Stress urinary incontinence</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Tubulointerstitial nephritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ureterolithiasis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Urinary hesitation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Balanoposthitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="3818"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Breast enlargement</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cervical cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cervical dysplasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cervix haemorrhage uterine</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cystocele</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Prostatomegaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Rectocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Uterine mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acquired diaphragmatic eventration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" events="9" subjects_affected="6" subjects_at_risk="3818"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="26" subjects_affected="24" subjects_at_risk="3818"/>
                <counts group_id="E2" events="35" subjects_affected="31" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="3818"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Asthma-chronic obstructive pulmonary disease overlap syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Bronchial hyperreactivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="54" subjects_affected="42" subjects_at_risk="3818"/>
                <counts group_id="E2" events="70" subjects_affected="56" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Chronic respiratory failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="3818"/>
                <counts group_id="E2" events="19" subjects_affected="17" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Dyspnoea paroxysmal nocturnal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Idiopathic pulmonary fibrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Laryngeal stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Nasal polyps</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Nasal septum deviation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Non-cardiogenic pulmonary oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Obstructive airways disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pharyngeal oedema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pickwickian syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pneumothorax spontaneous</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pulmonary congestion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="3818"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3818"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pulmonary sarcoidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pulmonary veno-occlusive disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="23" subjects_affected="22" subjects_at_risk="3818"/>
                <counts group_id="E2" events="19" subjects_affected="18" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Respiratory tract inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Dermal cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="3818"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Diabetic neuropathic ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hidradenitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypersensitivity vasculitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Neuropathic ulcer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Pemphigoid</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Skin necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="3818"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Skin ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Stasis dermatitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Social stay hospitalisation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Abdominal hernia repair</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Abdominal panniculectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Amputation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Angioplasty</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm repair</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Aortic stent insertion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Aortic valve replacement</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac ablation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker battery replacement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker insertion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker replacement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Cataract operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Colectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Colostomy closure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Coronary arterial stent insertion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Coronary artery bypass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Duodenal switch</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastrectomy</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Gastric bypass</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hernia repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hip arthroplasty</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hysterectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator insertion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator replacement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Inguinal hernia repair</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intervertebral disc operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intra-ocular injection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Jejunostomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Joint arthroplasty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Knee operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Leg amputation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Metabolic surgery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Oesophagectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Rotator cuff repair</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Roux loop conversion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Spinal decompression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Spinal fusion surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Spinal laminectomy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Thyroidectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Transurethral prostatectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Umbilical hernia repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated hypertension</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Angiopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Arterial haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Blood pressure inadequately controlled</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="3818"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Dry gangrene</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Embolism arterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Embolism venous</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Essential hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Extremity necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="19" subjects_affected="17" subjects_at_risk="3818"/>
                <counts group_id="E2" events="24" subjects_affected="23" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3818"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypertensive emergency</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="3818"/>
                <counts group_id="E2" events="15" subjects_affected="14" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Ischaemic limb pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Leriche syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Lymphocele</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Malignant hypertension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Microangiopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Obstructive shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3818"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="3818"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Peripheral artery aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Peripheral artery occlusion</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Peripheral artery stenosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Peripheral artery thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Peripheral embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3818"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="3818"/>
                <counts group_id="E2" events="17" subjects_affected="14" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Peripheral venous disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Reperfusion injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Shock haemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Subclavian steal syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Superior vena cava stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Temporal arteritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3818"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3818"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="3819"/>
              </event>
              <event>
                <sub_title>Vascular insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3818"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3819"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>“At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property”</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Global Clinical Registry (GCR, 1452)</name_or_title>
      <organization>Novo Nordisk A/S</organization>
      <email>clinicaltrials@novonordisk.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

